APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Omadacycline API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Omadacycline API Market Analysis and Forecast 2026-2032

Report ID 173320920220 December 2025206 pages

Choose your research edition.

Industry ResearchOmadacycline API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Omadacycline API Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Omadacycline API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omadacycline API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Omadacycline API Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Omadacycline API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Omadacycline API's global sales reached XX (kg) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Sichuan Qingmu Pharmaceutical as the global sales leader, a title it has maintained for several consecutive years. Notably, Sichuan Qingmu Pharmaceutical's performance in primary markets is also remarkable. In the Chinese market, sales were XX (kg), a change of XX% from the previous year. In Europe, sales were XX (kg), showing a year-on-year of XX%. In the US, sales were XX (kg), a year-on-year change of XX%.

The major global manufacturers in the Omadacycline API market include Sichuan Qingmu Pharmaceutical, Sichuan Kelun Pharmaceutical, Sichuan Aobang Gude Pharmaceutical, Shanghai Desano Chemical Pharmaceutical, Asymchem Laboratories, Hubei Tianshu Pharmaceutical and Paratek Pharmaceuticals, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Omadacycline API production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Omadacycline API by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Omadacycline API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Omadacycline API, also provides the consumption of main regions and countries. Of the upcoming market potential for Omadacycline API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Omadacycline API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Omadacycline API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Omadacycline API sales, projected growth trends, production technology, application and end-user industry.

Omadacycline API Segment by Company

Sichuan Qingmu Pharmaceutical

Sichuan Kelun Pharmaceutical

Sichuan Aobang Gude Pharmaceutical

Shanghai Desano Chemical Pharmaceutical

Asymchem Laboratories

Hubei Tianshu Pharmaceutical

Paratek Pharmaceuticals

Omadacycline API Segment by Type

Purity 97%-99%

Purity Above 99%

Omadacycline API Segment by Application

Injection

Tablets

Omadacycline API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omadacycline API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omadacycline API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omadacycline API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Omadacycline API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Omadacycline API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Omadacycline API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Omadacycline API sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Omadacycline API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity 97%-99% Major Manufacturers Table 3. Purity Above 99% Major Manufacturers Table 4. Global Omadacycline API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Injection Major Manufacturers Table 6. Tablets Major Manufacturers Table 7. Omadacycline API Industry Trends Table 8. Omadacycline API Industry Drivers Table 9. Omadacycline API Industry Opportunities and Challenges Table 10. Omadacycline API Industry Restraints Table 11. Global Omadacycline API Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 12. Global Omadacycline API Production by Region (2021-2026) & (kg) Table 13. Global Omadacycline API Production by Region (2027-2032) & (kg) Table 14. Global Omadacycline API Production Market Share by Region (2021-2026) Table 15. Global Omadacycline API Production Market Share by Region (2027-2032) Table 16. Global Omadacycline API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Omadacycline API Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Omadacycline API Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Omadacycline API Revenue Market Share by Region (2021-2026) Table 20. Global Omadacycline API Revenue Market Share by Region (2027-2032) Table 21. Global Omadacycline API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 22. Global Omadacycline API Sales by Region (2021-2026) & (kg) Table 23. Global Omadacycline API Sales by Region (2027-2032) & (kg) Table 24. Global Omadacycline API Sales Market Share by Region (2021-2026) Table 25. Global Omadacycline API Sales Market Share by Region (2027-2032) Table 26. Global Omadacycline API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Omadacycline API Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Omadacycline API Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Omadacycline API Sales Market Share by Manufacturers (2021-2026) Table 30. Global Omadacycline API Sales Price (USD/kg) of Manufacturers (2021-2026) Table 31. Global Omadacycline API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Omadacycline API Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Omadacycline API Manufacturers, Product Type & Application Table 34. Global Omadacycline API Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Omadacycline API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Omadacycline API Revenue Market Share by Type (2021-2026) Table 40. Global Omadacycline API Revenue Market Share by Type (2027-2032) Table 41. Global Omadacycline API Sales by Type (2021-2026) & (kg) Table 42. Global Omadacycline API Sales by Type (2027-2032) & (kg) Table 43. Global Omadacycline API Sales Market Share by Type (2021-2026) Table 44. Global Omadacycline API Sales Market Share by Type (2027-2032) Table 45. Global Omadacycline API Price by Type (2021-2026) & (USD/kg) Table 46. Global Omadacycline API Price by Type (2027-2032) & (USD/kg) Table 47. Global Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Omadacycline API Revenue Market Share by Application (2021-2026) Table 50. Global Omadacycline API Revenue Market Share by Application (2027-2032) Table 51. Global Omadacycline API Sales by Application (2021-2026) & (kg) Table 52. Global Omadacycline API Sales by Application (2027-2032) & (kg) Table 53. Global Omadacycline API Sales Market Share by Application (2021-2026) Table 54. Global Omadacycline API Sales Market Share by Application (2027-2032) Table 55. Global Omadacycline API Price by Application (2021-2026) & (USD/kg) Table 56. Global Omadacycline API Price by Application (2027-2032) & (USD/kg) Table 57. Sichuan Qingmu Pharmaceutical Company Information Table 58. Sichuan Qingmu Pharmaceutical Business Overview Table 59. Sichuan Qingmu Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 60. Sichuan Qingmu Pharmaceutical Omadacycline API Product Portfolio Table 61. Sichuan Qingmu Pharmaceutical Recent Development Table 62. Sichuan Kelun Pharmaceutical Company Information Table 63. Sichuan Kelun Pharmaceutical Business Overview Table 64. Sichuan Kelun Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 65. Sichuan Kelun Pharmaceutical Omadacycline API Product Portfolio Table 66. Sichuan Kelun Pharmaceutical Recent Development Table 67. Sichuan Aobang Gude Pharmaceutical Company Information Table 68. Sichuan Aobang Gude Pharmaceutical Business Overview Table 69. Sichuan Aobang Gude Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 70. Sichuan Aobang Gude Pharmaceutical Omadacycline API Product Portfolio Table 71. Sichuan Aobang Gude Pharmaceutical Recent Development Table 72. Shanghai Desano Chemical Pharmaceutical Company Information Table 73. Shanghai Desano Chemical Pharmaceutical Business Overview Table 74. Shanghai Desano Chemical Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Shanghai Desano Chemical Pharmaceutical Omadacycline API Product Portfolio Table 76. Shanghai Desano Chemical Pharmaceutical Recent Development Table 77. Asymchem Laboratories Company Information Table 78. Asymchem Laboratories Business Overview Table 79. Asymchem Laboratories Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Asymchem Laboratories Omadacycline API Product Portfolio Table 81. Asymchem Laboratories Recent Development Table 82. Hubei Tianshu Pharmaceutical Company Information Table 83. Hubei Tianshu Pharmaceutical Business Overview Table 84. Hubei Tianshu Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Hubei Tianshu Pharmaceutical Omadacycline API Product Portfolio Table 86. Hubei Tianshu Pharmaceutical Recent Development Table 87. Paratek Pharmaceuticals Company Information Table 88. Paratek Pharmaceuticals Business Overview Table 89. Paratek Pharmaceuticals Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. Paratek Pharmaceuticals Omadacycline API Product Portfolio Table 91. Paratek Pharmaceuticals Recent Development Table 92. North America Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Omadacycline API Sales by Type (2021-2026) & (kg) Table 95. North America Omadacycline API Sales by Type (2027-2032) & (kg) Table 96. North America Omadacycline API Sales Price by Type (2021-2026) & (USD/kg) Table 97. North America Omadacycline API Sales Price by Type (2027-2032) & (USD/kg) Table 98. North America Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Omadacycline API Sales by Application (2021-2026) & (kg) Table 101. North America Omadacycline API Sales by Application (2027-2032) & (kg) Table 102. North America Omadacycline API Sales Price by Application (2021-2026) & (USD/kg) Table 103. North America Omadacycline API Sales Price by Application (2027-2032) & (USD/kg) Table 104. North America Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Omadacycline API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Omadacycline API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Omadacycline API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 108. North America Omadacycline API Sales by Country (2021-2026) & (kg) Table 109. North America Omadacycline API Sales by Country (2027-2032) & (kg) Table 110. North America Omadacycline API Sales Price by Country (2021-2026) & (USD/kg) Table 111. North America Omadacycline API Sales Price by Country (2027-2032) & (USD/kg) Table 112. United States Omadacycline API Revenue (2021-2032) & (US$ Million) Table 113. Canada Omadacycline API Revenue (2021-2032) & (US$ Million) Table 114. Mexico Omadacycline API Revenue (2021-2032) & (US$ Million) Table 115. Europe Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Omadacycline API Sales by Type (2021-2026) & (kg) Table 118. Europe Omadacycline API Sales by Type (2027-2032) & (kg) Table 119. Europe Omadacycline API Sales Price by Type (2021-2026) & (USD/kg) Table 120. Europe Omadacycline API Sales Price by Type (2027-2032) & (USD/kg) Table 121. Europe Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Omadacycline API Sales by Application (2021-2026) & (kg) Table 124. Europe Omadacycline API Sales by Application (2027-2032) & (kg) Table 125. Europe Omadacycline API Sales Price by Application (2021-2026) & (USD/kg) Table 126. Europe Omadacycline API Sales Price by Application (2027-2032) & (USD/kg) Table 127. Europe Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Omadacycline API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Omadacycline API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Omadacycline API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 131. Europe Omadacycline API Sales by Country (2021-2026) & (kg) Table 132. Europe Omadacycline API Sales by Country (2027-2032) & (kg) Table 133. Europe Omadacycline API Sales Price by Country (2021-2026) & (USD/kg) Table 134. Europe Omadacycline API Sales Price by Country (2027-2032) & (USD/kg) Table 135. Germany Omadacycline API Revenue (2021-2032) & (US$ Million) Table 136. France Omadacycline API Revenue (2021-2032) & (US$ Million) Table 137. U.K. Omadacycline API Revenue (2021-2032) & (US$ Million) Table 138. Italy Omadacycline API Revenue (2021-2032) & (US$ Million) Table 139. Russia Omadacycline API Revenue (2021-2032) & (US$ Million) Table 140. Spain Omadacycline API Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Omadacycline API Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Omadacycline API Revenue (2021-2032) & (US$ Million) Table 143. Sweden Omadacycline API Revenue (2021-2032) & (US$ Million) Table 144. Poland Omadacycline API Revenue (2021-2032) & (US$ Million) Table 145. China Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 146. China Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 147. China Omadacycline API Sales by Type (2021-2026) & (kg) Table 148. China Omadacycline API Sales by Type (2027-2032) & (kg) Table 149. China Omadacycline API Sales Price by Type (2021-2026) & (USD/kg) Table 150. China Omadacycline API Sales Price by Type (2027-2032) & (USD/kg) Table 151. China Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 152. China Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 153. China Omadacycline API Sales by Application (2021-2026) & (kg) Table 154. China Omadacycline API Sales by Application (2027-2032) & (kg) Table 155. China Omadacycline API Sales Price by Application (2021-2026) & (USD/kg) Table 156. China Omadacycline API Sales Price by Application (2027-2032) & (USD/kg) Table 157. Asia Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Omadacycline API Sales by Type (2021-2026) & (kg) Table 160. Asia Omadacycline API Sales by Type (2027-2032) & (kg) Table 161. Asia Omadacycline API Sales Price by Type (2021-2026) & (USD/kg) Table 162. Asia Omadacycline API Sales Price by Type (2027-2032) & (USD/kg) Table 163. Asia Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Omadacycline API Sales by Application (2021-2026) & (kg) Table 166. Asia Omadacycline API Sales by Application (2027-2032) & (kg) Table 167. Asia Omadacycline API Sales Price by Application (2021-2026) & (USD/kg) Table 168. Asia Omadacycline API Sales Price by Application (2027-2032) & (USD/kg) Table 169. Asia Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Omadacycline API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Omadacycline API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Omadacycline API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 173. Asia Omadacycline API Sales by Country (2021-2026) & (kg) Table 174. Asia Omadacycline API Sales by Country (2027-2032) & (kg) Table 175. Asia Omadacycline API Sales Price by Country (2021-2026) & (USD/kg) Table 176. Asia Omadacycline API Sales Price by Country (2027-2032) & (USD/kg) Table 177. Japan Omadacycline API Revenue (2021-2032) & (US$ Million) Table 178. South Korea Omadacycline API Revenue (2021-2032) & (US$ Million) Table 179. India Omadacycline API Revenue (2021-2032) & (US$ Million) Table 180. Australia Omadacycline API Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Omadacycline API Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Omadacycline API Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Omadacycline API Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Omadacycline API Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Omadacycline API Sales by Type (2021-2026) & (kg) Table 186. SAMEA Omadacycline API Sales by Type (2027-2032) & (kg) Table 187. SAMEA Omadacycline API Sales Price by Type (2021-2026) & (USD/kg) Table 188. SAMEA Omadacycline API Sales Price by Type (2027-2032) & (USD/kg) Table 189. SAMEA Omadacycline API Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Omadacycline API Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Omadacycline API Sales by Application (2021-2026) & (kg) Table 192. SAMEA Omadacycline API Sales by Application (2027-2032) & (kg) Table 193. SAMEA Omadacycline API Sales Price by Application (2021-2026) & (USD/kg) Table 194. SAMEA Omadacycline API Sales Price by Application (2027-2032) & (USD/kg) Table 195. SAMEA Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Omadacycline API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Omadacycline API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Omadacycline API Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 199. SAMEA Omadacycline API Sales by Country (2021-2026) & (kg) Table 200. SAMEA Omadacycline API Sales by Country (2027-2032) & (kg) Table 201. SAMEA Omadacycline API Sales Price by Country (2021-2026) & (USD/kg) Table 202. SAMEA Omadacycline API Sales Price by Country (2027-2032) & (USD/kg) Table 203. Brazil Omadacycline API Revenue (2021-2032) & (US$ Million) Table 204. Argentina Omadacycline API Revenue (2021-2032) & (US$ Million) Table 205. Chile Omadacycline API Revenue (2021-2032) & (US$ Million) Table 206. Colombia Omadacycline API Revenue (2021-2032) & (US$ Million) Table 207. Peru Omadacycline API Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Omadacycline API Revenue (2021-2032) & (US$ Million) Table 209. Israel Omadacycline API Revenue (2021-2032) & (US$ Million) Table 210. UAE Omadacycline API Revenue (2021-2032) & (US$ Million) Table 211. Turkey Omadacycline API Revenue (2021-2032) & (US$ Million) Table 212. Iran Omadacycline API Revenue (2021-2032) & (US$ Million) Table 213. Egypt Omadacycline API Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Omadacycline API Distributors List Table 217. Omadacycline API Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Omadacycline API Product Image Figure 2. Global Omadacycline API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omadacycline API Market Size Share 2021 VS 2025 VS 2032 Figure . Purity 97%-99% Image Figure 1. Purity Above 99% Image Figure 2. Global Omadacycline API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omadacycline API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Tablets Image Figure 6. Global Omadacycline API Capacity, Capacity Utilization (2021-2032) & (kg) Figure 7. Global Omadacycline API Production by Region: 2021 VS 2025 VS 2032 (kg) Figure 8. Global Omadacycline API Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Omadacycline API Production Market Share by Region (2021-2032) Figure 10. North America Omadacycline API Production Growth Rate (2021-2032) & (kg) Figure 11. Europe Omadacycline API Production Growth Rate (2021-2032) & (kg) Figure 12. China Omadacycline API Production Growth Rate (2021-2032) & (kg) Figure 13. Japan Omadacycline API Production Growth Rate (2021-2032) & (kg) Figure 14. Global Omadacycline API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Omadacycline API Revenue (2021-2032) & (US$ Million) Figure 16. Global Omadacycline API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Omadacycline API Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Omadacycline API Revenue Market Share by Region (2021-2032) Figure 19. Global Omadacycline API Sales (2021-2032) & (kg) Figure 20. Global Omadacycline API Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 21. Global Omadacycline API Sales Market Share by Region (2021-2032) Figure 22. North America Omadacycline API Sales YoY (2021-2032) & (kg) Figure 23. Europe Omadacycline API Sales YoY (2021-2032) & (kg) Figure 24. China Omadacycline API Sales YoY (2021-2032) & (kg) Figure 25. Asia (Excluding China) Omadacycline API Sales YoY (2021-2032) & (kg) Figure 26. South America, Middle East and Africa Omadacycline API Sales YoY (2021-2032) & (kg) Figure 27. Global Omadacycline API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Omadacycline API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Omadacycline API Revenue Market Share by Type (2021-2032) Figure 31. Global Omadacycline API Sales Market Share by Type (2021-2032) Figure 32. Global Omadacycline API Revenue Market Share by Application (2021-2032) Figure 33. Global Omadacycline API Sales Market Share by Application (2021-2032) Figure 34. North America Omadacycline API Revenue Share by Type (2021-2032) Figure 35. North America Omadacycline API Sales Share by Type (2021-2032) Figure 36. North America Omadacycline API Revenue Share by Application (2021-2032) Figure 37. North America Omadacycline API Sales Share by Application (2021-2032) Figure 38. North America Omadacycline API Revenue Share by Country (2021-2032) Figure 39. North America Omadacycline API Sales Share by Country (2021-2032) Figure 40. Europe Omadacycline API Revenue Share by Type (2021-2032) Figure 41. Europe Omadacycline API Sales Share by Type (2021-2032) Figure 42. Europe Omadacycline API Revenue Share by Application (2021-2032) Figure 43. Europe Omadacycline API Sales Share by Application (2021-2032) Figure 44. Europe Omadacycline API Revenue Share by Country (2021-2032) Figure 45. Europe Omadacycline API Sales Share by Country (2021-2032) Figure 46. China Omadacycline API Revenue Share by Type (2021-2032) Figure 47. China Omadacycline API Sales Share by Type (2021-2032) Figure 48. China Omadacycline API Revenue Share by Application (2021-2032) Figure 49. China Omadacycline API Sales Share by Application (2021-2032) Figure 50. Asia Omadacycline API Revenue Share by Type (2021-2032) Figure 51. Asia Omadacycline API Sales Share by Type (2021-2032) Figure 52. Asia Omadacycline API Revenue Share by Application (2021-2032) Figure 53. Asia Omadacycline API Sales Share by Application (2021-2032) Figure 54. Asia Omadacycline API Revenue Share by Country (2021-2032) Figure 55. Asia Omadacycline API Sales Share by Country (2021-2032) Figure 56. SAMEA Omadacycline API Revenue Share by Type (2021-2032) Figure 57. SAMEA Omadacycline API Sales Share by Type (2021-2032) Figure 58. SAMEA Omadacycline API Revenue Share by Application (2021-2032) Figure 59. SAMEA Omadacycline API Sales Share by Application (2021-2032) Figure 60. SAMEA Omadacycline API Revenue Share by Country (2021-2032) Figure 61. SAMEA Omadacycline API Sales Share by Country (2021-2032) Figure 62. Omadacycline API Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Omadacycline API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 97%-99%
  • Purity Above 99%
Applications
  • Injection
  • Tablets
Companies covered
  • Sichuan Qingmu Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Sichuan Aobang Gude Pharmaceutical
  • Shanghai Desano Chemical Pharmaceutical
  • Asymchem Laboratories
  • Hubei Tianshu Pharmaceutical
  • Paratek Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Omadacycline API Market by Type
  3. 1.2.1 Global Omadacycline API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity 97%-99%
  5. 1.2.3 Purity Above 99%
  6. 1.3 Omadacycline API Market by Application
  7. 1.3.1 Global Omadacycline API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Injection
  9. 1.3.3 Tablets
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Omadacycline API Market Dynamics
  1. 2.1 Omadacycline API Industry Trends
  2. 2.2 Omadacycline API Industry Drivers
  3. 2.3 Omadacycline API Industry Opportunities and Challenges
  4. 2.4 Omadacycline API Industry Restraints
3 Global Omadacycline API Production Overview
  1. 3.1 Global Omadacycline API Production Capacity (2021-2032)
  2. 3.2 Global Omadacycline API Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Omadacycline API Production by Region
  4. 3.3.1 Global Omadacycline API Production by Region (2021-2026)
  5. 3.3.2 Global Omadacycline API Production by Region (2027-2032)
  6. 3.3.3 Global Omadacycline API Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Omadacycline API Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Omadacycline API Revenue by Region
  3. 4.2.1 Global Omadacycline API Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Omadacycline API Revenue by Region (2021-2026)
  5. 4.2.3 Global Omadacycline API Revenue by Region (2027-2032)
  6. 4.2.4 Global Omadacycline API Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Omadacycline API Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Omadacycline API Sales by Region
  9. 4.4.1 Global Omadacycline API Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Omadacycline API Sales by Region (2021-2026)
  11. 4.4.3 Global Omadacycline API Sales by Region (2027-2032)
  12. 4.4.4 Global Omadacycline API Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Omadacycline API Revenue by Manufacturers
  2. 5.1.1 Global Omadacycline API Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Omadacycline API Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Omadacycline API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Omadacycline API Sales by Manufacturers
  6. 5.2.1 Global Omadacycline API Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Omadacycline API Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Omadacycline API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Omadacycline API Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Omadacycline API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Omadacycline API Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Omadacycline API Manufacturers, Product Type & Application
  13. 5.7 Global Omadacycline API Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Omadacycline API Market CR5 and HHI
  16. 5.8.2 2025 Omadacycline API Tier 1, Tier 2, and Tier 3
6 Omadacycline API Market by Type
  1. 6.1 Global Omadacycline API Revenue by Type
  2. 6.1.1 Global Omadacycline API Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Omadacycline API Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Omadacycline API Sales by Type
  5. 6.2.1 Global Omadacycline API Sales by Type (2021-2032) & (kg)
  6. 6.2.2 Global Omadacycline API Sales Market Share by Type (2021-2032)
  7. 6.3 Global Omadacycline API Price by Type
7 Omadacycline API Market by Application
  1. 7.1 Global Omadacycline API Revenue by Application
  2. 7.1.1 Global Omadacycline API Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Omadacycline API Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Omadacycline API Sales by Application
  5. 7.2.1 Global Omadacycline API Sales by Application (2021-2032) & (kg)
  6. 7.2.2 Global Omadacycline API Sales Market Share by Application (2021-2032)
  7. 7.3 Global Omadacycline API Price by Application
8 Company Profiles
  1. 8.1 Sichuan Qingmu Pharmaceutical
  2. 8.1.1 Sichuan Qingmu Pharmaceutical Company Information
  3. 8.1.2 Sichuan Qingmu Pharmaceutical Business Overview
  4. 8.1.3 Sichuan Qingmu Pharmaceutical Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Qingmu Pharmaceutical Omadacycline API Product Portfolio
  6. 8.1.5 Sichuan Qingmu Pharmaceutical Recent Developments
  7. 8.2 Sichuan Kelun Pharmaceutical
  8. 8.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 8.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Kelun Pharmaceutical Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Kelun Pharmaceutical Omadacycline API Product Portfolio
  12. 8.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 8.3 Sichuan Aobang Gude Pharmaceutical
  14. 8.3.1 Sichuan Aobang Gude Pharmaceutical Company Information
  15. 8.3.2 Sichuan Aobang Gude Pharmaceutical Business Overview
  16. 8.3.3 Sichuan Aobang Gude Pharmaceutical Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Aobang Gude Pharmaceutical Omadacycline API Product Portfolio
  18. 8.3.5 Sichuan Aobang Gude Pharmaceutical Recent Developments
  19. 8.4 Shanghai Desano Chemical Pharmaceutical
  20. 8.4.1 Shanghai Desano Chemical Pharmaceutical Company Information
  21. 8.4.2 Shanghai Desano Chemical Pharmaceutical Business Overview
  22. 8.4.3 Shanghai Desano Chemical Pharmaceutical Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Desano Chemical Pharmaceutical Omadacycline API Product Portfolio
  24. 8.4.5 Shanghai Desano Chemical Pharmaceutical Recent Developments
  25. 8.5 Asymchem Laboratories
  26. 8.5.1 Asymchem Laboratories Company Information
  27. 8.5.2 Asymchem Laboratories Business Overview
  28. 8.5.3 Asymchem Laboratories Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Asymchem Laboratories Omadacycline API Product Portfolio
  30. 8.5.5 Asymchem Laboratories Recent Developments
  31. 8.6 Hubei Tianshu Pharmaceutical
  32. 8.6.1 Hubei Tianshu Pharmaceutical Company Information
  33. 8.6.2 Hubei Tianshu Pharmaceutical Business Overview
  34. 8.6.3 Hubei Tianshu Pharmaceutical Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Tianshu Pharmaceutical Omadacycline API Product Portfolio
  36. 8.6.5 Hubei Tianshu Pharmaceutical Recent Developments
  37. 8.7 Paratek Pharmaceuticals
  38. 8.7.1 Paratek Pharmaceuticals Company Information
  39. 8.7.2 Paratek Pharmaceuticals Business Overview
  40. 8.7.3 Paratek Pharmaceuticals Omadacycline API Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Paratek Pharmaceuticals Omadacycline API Product Portfolio
  42. 8.7.5 Paratek Pharmaceuticals Recent Developments
9 North America
  1. 9.1 North America Omadacycline API Market Size by Type
  2. 9.1.1 North America Omadacycline API Revenue by Type (2021-2032)
  3. 9.1.2 North America Omadacycline API Sales by Type (2021-2032)
  4. 9.1.3 North America Omadacycline API Price by Type (2021-2032)
  5. 9.2 North America Omadacycline API Market Size by Application
  6. 9.2.1 North America Omadacycline API Revenue by Application (2021-2032)
  7. 9.2.2 North America Omadacycline API Sales by Application (2021-2032)
  8. 9.2.3 North America Omadacycline API Price by Application (2021-2032)
  9. 9.3 North America Omadacycline API Market Size by Country
  10. 9.3.1 North America Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Omadacycline API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Omadacycline API Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Omadacycline API Market Size by Type
  2. 10.1.1 Europe Omadacycline API Revenue by Type (2021-2032)
  3. 10.1.2 Europe Omadacycline API Sales by Type (2021-2032)
  4. 10.1.3 Europe Omadacycline API Price by Type (2021-2032)
  5. 10.2 Europe Omadacycline API Market Size by Application
  6. 10.2.1 Europe Omadacycline API Revenue by Application (2021-2032)
  7. 10.2.2 Europe Omadacycline API Sales by Application (2021-2032)
  8. 10.2.3 Europe Omadacycline API Price by Application (2021-2032)
  9. 10.3 Europe Omadacycline API Market Size by Country
  10. 10.3.1 Europe Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Omadacycline API Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Omadacycline API Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Omadacycline API Market Size by Type
  2. 11.1.1 China Omadacycline API Revenue by Type (2021-2032)
  3. 11.1.2 China Omadacycline API Sales by Type (2021-2032)
  4. 11.1.3 China Omadacycline API Price by Type (2021-2032)
  5. 11.2 China Omadacycline API Market Size by Application
  6. 11.2.1 China Omadacycline API Revenue by Application (2021-2032)
  7. 11.2.2 China Omadacycline API Sales by Application (2021-2032)
  8. 11.2.3 China Omadacycline API Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Omadacycline API Market Size by Type
  2. 12.1.1 Asia Omadacycline API Revenue by Type (2021-2032)
  3. 12.1.2 Asia Omadacycline API Sales by Type (2021-2032)
  4. 12.1.3 Asia Omadacycline API Price by Type (2021-2032)
  5. 12.2 Asia Omadacycline API Market Size by Application
  6. 12.2.1 Asia Omadacycline API Revenue by Application (2021-2032)
  7. 12.2.2 Asia Omadacycline API Sales by Application (2021-2032)
  8. 12.2.3 Asia Omadacycline API Price by Application (2021-2032)
  9. 12.3 Asia Omadacycline API Market Size by Country
  10. 12.3.1 Asia Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Omadacycline API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Omadacycline API Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Omadacycline API Market Size by Type
  2. 13.1.1 SAMEA Omadacycline API Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Omadacycline API Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Omadacycline API Price by Type (2021-2032)
  5. 13.2 SAMEA Omadacycline API Market Size by Application
  6. 13.2.1 SAMEA Omadacycline API Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Omadacycline API Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Omadacycline API Price by Application (2021-2032)
  9. 13.3 SAMEA Omadacycline API Market Size by Country
  10. 13.3.1 SAMEA Omadacycline API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Omadacycline API Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Omadacycline API Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Omadacycline API Value Chain Analysis
  2. 14.1.1 Omadacycline API Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Omadacycline API Production Mode & Process
  6. 14.2 Omadacycline API Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Omadacycline API Distributors
  9. 14.2.3 Omadacycline API Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst